Literature DB >> 4267001

The white matter in G M2 gangliosidosis. A comparative histopathological and biochemical study.

C Haberland, E Brunngraber, L Witting, B Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4267001     DOI： 10.1007/bf00691417

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  27 in total

1.  [TAY-SACHS DISEASE WITH EXTENSIVE DAMAGE OF THE WHITE MATTER. APROPOS OF 2 ANATOMO-CLINICAL CASES].

Authors:  M FARDEAU; J LAPRESLE
Journal:  Rev Neurol (Paris)       Date:  1963-08       Impact factor: 2.607

2.  A chemical investigation of the defects of myelination in phenylketonuria.

Authors:  L CROME; V TYMMS; L I WOOLF
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-05       Impact factor: 10.154

3.  [Infantile amaurotic idiocy with serious changes of the white matter].

Authors:  S THIEFFRY; I BERTRAND; E BARGETON; G W EDGAR; M ARTHUIS
Journal:  Rev Neurol (Paris)       Date:  1960-02       Impact factor: 2.607

4.  [Significance of demyelinization in familial amaurotic idiocy; EEG, histochemical & biochemical researches].

Authors:  M BERARD-BADIER; J E PAILLAS; H GASTAUT; G W EDGAR
Journal:  Psychiatr Neurol (Basel)       Date:  1958 Jan-Feb

5.  Determination of gangliosides, glycoproteins, and glycosaminoglycans in brain tissue.

Authors:  E G Brunngraber; B D Brown; H Hof
Journal:  Clin Chim Acta       Date:  1971-04       Impact factor: 3.786

6.  Effect of sciatic neurectomy on myelinogenesis in the rat spinal cord.

Authors:  J R Kingsley; G H Collins; W K Converse
Journal:  Exp Neurol       Date:  1970-03       Impact factor: 5.330

7.  Isolation and characterization of glycosaminoglycans in human brain of different age groups.

Authors:  M Singh; B K Bachhawat
Journal:  J Neurochem       Date:  1968-03       Impact factor: 5.372

8.  Morphological, histochemical and biochemical studies on a case of systemic late infantile lipidosis (generalized gangliosidosis).

Authors:  K Suzuki; G C Chen
Journal:  J Neuropathol Exp Neurol       Date:  1968-01       Impact factor: 3.685

9.  A comparison of cerebrosides, proteolipid proteins, and cholesterol as indices of myelin in the architecture of rat cerebrum.

Authors:  N H Bass; H H Hess
Journal:  J Neurochem       Date:  1969-05       Impact factor: 5.372

10.  Quantitative analysis of brain and spinach leaf lipids employing silicic acid column chromatography and acetone for elution of glycolipids.

Authors:  G Rouser; G Kritchevsky; G Simon; G J Nelson
Journal:  Lipids       Date:  1967-01       Impact factor: 1.880
View more
  6 in total

1.  Reversibility of neuropathology in Tay-Sachs-related diseases.

Authors:  María-Begoña Cachón-González; Susan Z Wang; Robin Ziegler; Seng H Cheng; Timothy M Cox
Journal:  Hum Mol Genet       Date:  2013-09-20       Impact factor: 6.150

Review 2.  Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms.

Authors:  Marjo S van der Knaap; Marianna Bugiani
Journal:  Acta Neuropathol       Date:  2017-06-21       Impact factor: 17.088

Review 3.  Genetics and Therapies for GM2 Gangliosidosis.

Authors:  Maria Begona Cachon-Gonzalez; Eva Zaccariotto; Timothy Martin Cox
Journal:  Curr Gene Ther       Date:  2018       Impact factor: 4.391

4.  Plasma neurofilament light, glial fibrillary acidic protein and lysosphingolipid biomarkers for pharmacodynamics and disease monitoring of GM2 and GM1 gangliosidoses patients.

Authors:  Richard W D Welford; Herve Farine; Michel Steiner; Marco Garzotti; Kostantin Dobrenis; Claudia Sievers; Daniel S Strasser; Yasmina Amraoui; Peter M A Groenen; Roberto Giugliani; Eugen Mengel
Journal:  Mol Genet Metab Rep       Date:  2022-02-01

5.  Therapeutic advantages of combined gene/cell therapy strategies in a murine model of GM2 gangliosidosis.

Authors:  Davide Sala; Francesca Ornaghi; Francesco Morena; Chiara Argentati; Manuela Valsecchi; Valeria Alberizzi; Roberta Di Guardo; Alessandra Bolino; Massimo Aureli; Sabata Martino; Angela Gritti
Journal:  Mol Ther Methods Clin Dev       Date:  2022-03-16       Impact factor: 6.698

Review 6.  GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies.

Authors:  Andrés Felipe Leal; Eliana Benincore-Flórez; Daniela Solano-Galarza; Rafael Guillermo Garzón Jaramillo; Olga Yaneth Echeverri-Peña; Diego A Suarez; Carlos Javier Alméciga-Díaz; Angela Johana Espejo-Mojica
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.